Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 26.45 Billion JPY | 5.42% |
| 2022 | 25.09 Billion JPY | 41.37% |
| 2021 | 17.74 Billion JPY | 17.46% |
| 2020 | 15.11 Billion JPY | 3.77% |
| 2019 | 14.56 Billion JPY | -7.01% |
| 2018 | 15.65 Billion JPY | -5.67% |
| 2017 | 16.6 Billion JPY | -3.73% |
| 2016 | 17.24 Billion JPY | 16.91% |
| 2015 | 14.75 Billion JPY | -17.3% |
| 2014 | 17.83 Billion JPY | 5.37% |
| 2013 | 16.92 Billion JPY | -1.33% |
| 2012 | 17.15 Billion JPY | 12.31% |
| 2011 | 15.27 Billion JPY | -12.08% |
| 2010 | 17.37 Billion JPY | -8.81% |
| 2009 | 19.05 Billion JPY | -2.51% |
| 2008 | 19.54 Billion JPY | -0.54% |
| 2007 | 19.64 Billion JPY | 13.64% |
| 2006 | 17.28 Billion JPY | 25.24% |
| 2005 | 13.8 Billion JPY | 12.28% |
| 2004 | 12.29 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.54 Billion JPY | -34.45% |
| 2023 Q1 | 5.8 Billion JPY | -33.42% |
| 2023 Q2 | 6.07 Billion JPY | 4.72% |
| 2023 Q3 | 6.1 Billion JPY | 0.36% |
| 2023 Q4 | 8.46 Billion JPY | 38.77% |
| 2023 FY | 26.45 Billion JPY | 5.42% |
| 2022 Q1 | 4.04 Billion JPY | -15.74% |
| 2022 Q3 | 6.02 Billion JPY | -4.43% |
| 2022 Q4 | 8.71 Billion JPY | 44.77% |
| 2022 FY | 25.09 Billion JPY | 41.37% |
| 2022 Q2 | 6.3 Billion JPY | 55.74% |
| 2021 Q2 | 4.92 Billion JPY | 61.78% |
| 2021 FY | 17.74 Billion JPY | 17.46% |
| 2021 Q1 | 3.04 Billion JPY | -35.15% |
| 2021 Q3 | 4.98 Billion JPY | 1.31% |
| 2021 Q4 | 4.8 Billion JPY | -3.66% |
| 2020 Q1 | 3.17 Billion JPY | -29.32% |
| 2020 FY | 15.11 Billion JPY | 3.77% |
| 2020 Q4 | 4.69 Billion JPY | 37.26% |
| 2020 Q2 | 3.83 Billion JPY | 20.69% |
| 2020 Q3 | 3.41 Billion JPY | -10.78% |
| 2019 Q1 | 2.73 Billion JPY | -20.31% |
| 2019 Q2 | 3.65 Billion JPY | 34.01% |
| 2019 Q3 | 3.68 Billion JPY | 0.63% |
| 2019 FY | 14.56 Billion JPY | -7.01% |
| 2019 Q4 | 4.49 Billion JPY | 21.95% |
| 2018 Q2 | 5.16 Billion JPY | 39.18% |
| 2018 Q3 | 3.35 Billion JPY | -35.14% |
| 2018 Q4 | 3.42 Billion JPY | 2.22% |
| 2018 FY | 15.65 Billion JPY | -5.67% |
| 2018 Q1 | 3.71 Billion JPY | -27.26% |
| 2017 Q4 | 5.1 Billion JPY | 29.46% |
| 2017 Q3 | 3.94 Billion JPY | -5.61% |
| 2017 Q2 | 4.17 Billion JPY | 23.77% |
| 2017 FY | 16.6 Billion JPY | -3.73% |
| 2017 Q1 | 3.37 Billion JPY | -40.69% |
| 2016 FY | 17.24 Billion JPY | 16.91% |
| 2016 Q2 | 3.69 Billion JPY | 8.98% |
| 2016 Q3 | 4.47 Billion JPY | 21.04% |
| 2016 Q4 | 5.69 Billion JPY | 27.29% |
| 2016 Q1 | 3.38 Billion JPY | -21.68% |
| 2015 Q3 | 3.85 Billion JPY | 15.35% |
| 2015 Q2 | 3.34 Billion JPY | 4.01% |
| 2015 Q1 | 3.21 Billion JPY | -38.29% |
| 2015 FY | 14.75 Billion JPY | -17.3% |
| 2015 Q4 | 4.32 Billion JPY | 12.11% |
| 2014 Q4 | 5.21 Billion JPY | 14.13% |
| 2014 FY | 17.83 Billion JPY | 5.37% |
| 2014 Q3 | 4.56 Billion JPY | 9.64% |
| 2014 Q2 | 4.16 Billion JPY | 7.15% |
| 2014 Q1 | 3.88 Billion JPY | -28.49% |
| 2013 Q2 | 4.13 Billion JPY | 12.32% |
| 2013 Q1 | 3.68 Billion JPY | -33.09% |
| 2013 Q3 | 3.67 Billion JPY | -11.27% |
| 2013 FY | 16.92 Billion JPY | -1.33% |
| 2013 Q4 | 5.43 Billion JPY | 48.14% |
| 2012 Q2 | 3.46 Billion JPY | -13.45% |
| 2012 Q3 | 4.18 Billion JPY | 21.05% |
| 2012 FY | 17.15 Billion JPY | 12.31% |
| 2012 Q1 | 3.99 Billion JPY | -6.54% |
| 2012 Q4 | 5.5 Billion JPY | 31.36% |
| 2011 FY | 15.27 Billion JPY | -12.08% |
| 2011 Q4 | 4.27 Billion JPY | 0.18% |
| 2011 Q3 | 4.27 Billion JPY | 37.95% |
| 2011 Q2 | 3.09 Billion JPY | -14.65% |
| 2011 Q1 | 3.62 Billion JPY | -25.15% |
| 2010 Q4 | 4.84 Billion JPY | 14.53% |
| 2010 Q3 | 4.23 Billion JPY | -7.12% |
| 2010 Q1 | 3.73 Billion JPY | -24.88% |
| 2010 FY | 17.37 Billion JPY | -8.81% |
| 2010 Q2 | 4.55 Billion JPY | 21.92% |
| 2009 Q3 | 3.74 Billion JPY | -33.7% |
| 2009 Q4 | 4.97 Billion JPY | 32.7% |
| 2009 FY | 19.05 Billion JPY | -2.51% |
| 2009 Q1 | 4.67 Billion JPY | -18.8% |
| 2009 Q2 | 5.65 Billion JPY | 21.04% |
| 2008 Q3 | 4.25 Billion JPY | -1.95% |
| 2008 FY | 19.54 Billion JPY | -0.54% |
| 2008 Q4 | 5.75 Billion JPY | 35.08% |
| 2008 Q2 | 4.34 Billion JPY | 0.0% |
| 2007 FY | 19.64 Billion JPY | 13.64% |
| 2006 FY | 17.28 Billion JPY | 25.24% |
| 2005 FY | 13.8 Billion JPY | 12.28% |
| 2004 FY | 12.29 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| DNA Chip Research Inc. | 490.46 Million JPY | -5292.97% |
| Cosmo Bio Company,Limited | 9.34 Billion JPY | -183.196% |
| H.U. Group Holdings, Inc. | 236.95 Billion JPY | 88.837% |
| FALCO HOLDINGS Co., Ltd. | 43 Billion JPY | 38.497% |
| BML, Inc. | 137.96 Billion JPY | 80.828% |
| Human Metabolome Technologies, Inc. | 1.34 Billion JPY | -1865.597% |
| Precision System Science Co., Ltd. | 3.97 Billion JPY | -564.592% |